Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma ; volume:13 ; number:1 ; day:1 ; month:12 ; year:2013 ; pages:1-4 ; date:12.2013
BMC cancer ; 13, Heft 1 (1.12.2013), 1-4, 12.2013
- Urheber
-
Wolf, Sanne EJ
- Beteiligte Personen und Organisationen
-
Meenken, Christina
Moll, Annette C.
Haanen, John B.
van der Heijden, Michiel S.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-561
- URN
-
urn:nbn:de:1111-2016030410946
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wolf, Sanne EJ
- Meenken, Christina
- Moll, Annette C.
- Haanen, John B.
- van der Heijden, Michiel S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
METASTATIC MALIGNANT MELANOMA OF SKIN
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
METASTATIC MALIGNANT MELANOMA OF SKIN
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
METASTATIC MALIGNANT MELANOMA OF SKIN
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report